Progress in 5H[1]benzopyrano[4,3-d]pyrimidin-5-amine series: 2-methoxy derivatives effective as antiplatelet agents with analgesic activity

Farmaco

Volumn 57, Issue 9, 2002, Pages 753-758

  Bruno, Olga ^a   Brullo, Chiara ^a   Schenone, Silvia ^a   Ranise, Angelo ^a   Bondavalli, Francesco ^a   Barocelli, Elisabetta ^b   Tognolini, Massimiliano ^b   Magnanini, Francesca ^b   Ballabeni, Vigilio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

2 Methoxy 5H 1 benzopyrano 4,3 d pyrimidin 5 amines; Analgesic activity; Antiplatelet activity

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; COLLAGEN; PYRIMIDINE DERIVATIVE; ANALGESIC AGENT;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; IN VIVO STUDY; MALE; NONHUMAN; RAT; STOMACH MUCOSA LESION; STRUCTURE ACTIVITY RELATION; ANIMAL; DRUG EFFECT; GUINEA PIG; MOUSE; PAIN ASSESSMENT; STOMACH MUCOSA; SYNTHESIS; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ANALGESICS, NON-NARCOTIC; ANIMALS; ARACHIDONIC ACID; COLLAGEN; GASTRIC MUCOSA; GUINEA PIGS; MICE; PAIN MEASUREMENT; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PYRIMIDINES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036753668     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(02)01269-7     Document Type: Article

References (12)

1. Antiplatelet Trialist' Collaboration . Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. 308:1994;81-106.
2. Majid A., Delanty N., Kantor J. Antiplatelet agents for secondary prevention of ischemic stroke. Ann. Pharmacother. 35:2001;1241-1247.
3. Robless P., Mikhailidis D.P., Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infartion, stroke or vascular death in patients with peripheral vascular disease. Br. J. Surg. 88:2001;787-800.
4. Weksler B.B. Antiplatelet agents in stroke prevention. Cerebrovasc. Dis. 10:2000;41-48. and references cited therein.
5. Bruno O., Schenone S., Ranise A., Bondavalli F., Barocelli E., Ballabeni V., Chiavarini M., Bertoni S., Tognolini M., Impicciatore M. New policyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening. Bioorg. Med. Chem. 9:2001;629-636.
6. Bruno O., Schenone S., Barocelli E., Chiavarini M., Ballabeni V., Bertoni S. Synthesis and pharmacological screening of novel non-acid gastroprotective antipyretic antiinflammatory agents with antiplatelet properties. Arzn. Fors. Drug Res. 50:2000;140-147.
7. Bruno O., Brullo C., Ranise A., Schenone S., Bondavalli F., Barocelli E., Ballabeni V., Chiavarini M., Tognolini M., Impicciatore M. Synthesis and pharmacological evaluation of 2,5-cycloamino-5H[1]benzopyrano[4,3-d]pyrimidines endowed with in vitro antiplatelet activity. Bioorg. Med. Chem. Lett. 11:2001;1397-1400.
8. V. Ballabeni, E. Barocelli, M. Chiavarini, M. Tognolini, O. Bruno, M. Impicciatore, EPHAR 2001 Lyon, July 6-9, 2001.
9. Harnisch H. Chromon-3-carbaldehyde. Liebigs Ann. Chem. 765:1972;8-14.
10. Savi P., Herbert J.M. ADP receptors on platelets and ADP-selective antiaggregating agents. Med. Res. Rev. 16:1996;159-179.
11. Petersen U., Heitzer H. Heterocyclensynthesen mit 4-oxo-4H-chromen-3-carbaldehyd. Liebigs Ann. Chem. 9:1976;163-167.
12. Born G.V.R. Aggregation by ADP and its reversal. Nature. 194:1962;927-929.